INNPF News and Press, Innovative Properties Inc From 07/23/25

Innocan Pharma Announces Public Filing of Registration Statement for Proposed U.S. Public Offering Canada NewsWire HERZLIYA, Israel and CALGARY, Alberta , July 23, 2025 /CNW/ -- Innocan Pharma Corporation (" Innocan " or the " Company ") (CSE: INNO) (...

Innocan Pharma Announces Promising Results of LPT-CBD Administered to Gottingen Minipigs, providing a good translational model and Provides Corporate Update Canada NewsWire HERZLIYA, Israel and CALGARY, AB , July 3, 2025 /CNW/ -- Innocan Pharma Corporation (C...

Innocan Pharma Announces Presentation of Narrative Review on Long-Acting Synthetic Cannabidiol for Chronic Pain at PAINWEEK Conference Canada NewsWire HERZLIYA, Israel and CALGARY, AB , June 20, 2025 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: I...

Innocan Pharma Highlights Breakthrough Narrative Review on Liposomal Synthetic CBD for Chronic Pain: A Novel Non-Opioid Analgesic Approach Canada NewsWire HERZLIYA, Israel and CALGARY, AB , June 13, 2025 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: I...

Innocan Pharma Announces First Quarter 2025 Financial Results with Continued Strong Revenue Growth and Provides Corporate Update Canada NewsWire HERZLIYA, Israel and CALGARY, AB , May 28, 2025 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: I...

Innocan Pharma First Granted Patent in Mexico for its Topical Pain Relief Canada NewsWire Innocan's first fully-granted patent in Mexico Covers Innocan's proprietary cannabis-based pain relief topical Indication of Innocan's growing intellectual property portfolio ...

Innocan Pharma Broadens Intellectual Property Coverage for its Liposomal CBD Injection Across Asia and Announces Private Placement of Units Canada NewsWire Innovative Chronic Pain Treatment expand IP Protection in China's US$163 Billion Pharmaceutical Market HE...

Innocan Pharma Reports Full Year 2024 Results with Revenues more than Doubling to US $29.4 million Canada NewsWire HERZLIYA, Israel and CALGARY, AB , March 31, 2025 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the " Company " o...

Innocan Pharma Announces Closing of Debenture Unit Offering to its Largest Shareholder, Tamar Innovest Limited Canada NewsWire HERZLIYA, Israel and CALGARY, AB , March 7, 2025 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the " Co...

Innocan Pharma Announces Private Placement Offering of a Debenture Unit to its Largest Shareholder, Tamar Innovest Canada NewsWire HERZLIYA, Israel and CALGARY, AB , Feb. 27, 2025 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the " ...